Product Code: ETC9971662 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Nonmelanoma Skin Cancer Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Nonmelanoma Skin Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Nonmelanoma Skin Cancer Market - Industry Life Cycle |
3.4 United States (US) Nonmelanoma Skin Cancer Market - Porter's Five Forces |
3.5 United States (US) Nonmelanoma Skin Cancer Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 United States (US) Nonmelanoma Skin Cancer Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 United States (US) Nonmelanoma Skin Cancer Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Nonmelanoma Skin Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of nonmelanoma skin cancer in the US |
4.2.2 Advancements in diagnostic technologies for early detection |
4.2.3 Growing awareness about the importance of sun protection and skin cancer prevention |
4.3 Market Restraints |
4.3.1 High treatment costs associated with nonmelanoma skin cancer |
4.3.2 Limited access to specialized dermatologists in certain regions |
4.3.3 Adverse effects of current treatment options on patient quality of life |
5 United States (US) Nonmelanoma Skin Cancer Market Trends |
6 United States (US) Nonmelanoma Skin Cancer Market, By Types |
6.1 United States (US) Nonmelanoma Skin Cancer Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Nonmelanoma Skin Cancer Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 United States (US) Nonmelanoma Skin Cancer Market Revenues & Volume, By Radiation Therapy, 2021- 2031F |
6.1.4 United States (US) Nonmelanoma Skin Cancer Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.5 United States (US) Nonmelanoma Skin Cancer Market Revenues & Volume, By Photodynamic Therapy, 2021- 2031F |
6.2 United States (US) Nonmelanoma Skin Cancer Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Nonmelanoma Skin Cancer Market Revenues & Volume, By Basal Cell Carcinoma, 2021- 2031F |
6.2.3 United States (US) Nonmelanoma Skin Cancer Market Revenues & Volume, By Squamous Cell Carcinoma, 2021- 2031F |
6.3 United States (US) Nonmelanoma Skin Cancer Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Nonmelanoma Skin Cancer Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) Nonmelanoma Skin Cancer Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.4 United States (US) Nonmelanoma Skin Cancer Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 United States (US) Nonmelanoma Skin Cancer Market Import-Export Trade Statistics |
7.1 United States (US) Nonmelanoma Skin Cancer Market Export to Major Countries |
7.2 United States (US) Nonmelanoma Skin Cancer Market Imports from Major Countries |
8 United States (US) Nonmelanoma Skin Cancer Market Key Performance Indicators |
8.1 Average age of diagnosis for nonmelanoma skin cancer patients in the US |
8.2 Percentage of nonmelanoma skin cancer cases detected at an early stage |
8.3 Adoption rate of novel treatment modalities for nonmelanoma skin cancer |
9 United States (US) Nonmelanoma Skin Cancer Market - Opportunity Assessment |
9.1 United States (US) Nonmelanoma Skin Cancer Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 United States (US) Nonmelanoma Skin Cancer Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 United States (US) Nonmelanoma Skin Cancer Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Nonmelanoma Skin Cancer Market - Competitive Landscape |
10.1 United States (US) Nonmelanoma Skin Cancer Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Nonmelanoma Skin Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |